Data / Form D filings / Esanex, Inc.
Esanex, Inc.: Form D filings
Esanex, Inc., a pharmaceuticals company in Indianapolis, IN, filed 4 Form D notices with the SEC between 2012 and 2017. The latest, on April 10, 2017, reports $2.6 million sold of a $2.9 million offering to 4 investors.
Find out what Esanex, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 115 W. WASHINGTON ST., SUITE 1680 - SOUTH, Indianapolis, IN, 46204
- Phone
- (317) 429-0143
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1531658
The full lists. Form D filings in Indiana: 436 rows, $21.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 10, 2017 | New notice | $2,900,000 | $2,584,161 | $315,839 | 4 | Mar 27, 2017 | sec.gov |
| Dec 12, 2012 | Amendment | $15,500,000 | $15,500,000 | $0 | 4 | Apr 16, 2012 | sec.gov |
| Jun 13, 2012 | Amendment | $15,500,000 | $4,753,336 | $10,746,664 | 4 | Apr 16, 2012 | sec.gov |
| Apr 26, 2012 | New notice | $15,000,000 | $4,600,002 | $10,399,998 | 3 | Apr 16, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven E Hall | Executive Officer, Director | |
| Richard Edward Miller | Director | |
| S Edward Torres | Executive Officer | |
| Richard Edward Kent | Director |
Every Form D from the week of Apr 10, 2017 · All recent filings in Indiana · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Esanex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.